News
3h
Zacks Investment Research on MSNWhy Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-TermTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...
Finding a new place to work is a job in and of itself, as anyone who’s gone job-seeking in the last three or so years can ...
Bristol-Myers Squibb is trading near all-time high dividend and free cash flow yields. Learn why BMY stock is a Buy.
Tesla slides ahead of quarterly earnings scheduled for Tuesday, and Nvidia tumbles with the chip maker a victim of the ...
Soon after graduation this spring, Neha Bhat will start a job as a Global Marketing New Analyst for Goldman Sachs, a position ...
The simplified requirements for Camzyos are expected to ease prior contraindications, thereby simplifying treatment and ...
FDA approves Camzyos label update easing echo monitoring and lifting drug interaction limits, supported by 3.5 years of safety data and real-world use ...
Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector. UBS analyst ...
"Dr. Mekan brings a combined 18 years of experience in hematology and oncology across academic research, clinical practice ...
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences ...
Several states are reporting cases of measles, a highly contagious viral disease. Both children and adults can get measles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results